Cnbc

The $449/month workplace offering expands Lilly's direct-distribution model beyond individual consumers. With Medicare coverage launching and oral pills pending FDA approval, the timing suggests broader ambitions.

Media reports emphasize Bitcoin's drop to "lowest since November" while downplaying key factors: Trump's tariff threats, institutional demand paradoxes, and technical indicators. Our analysis reveals what the headlines missed.